---
title: "Ocrelizumab - Primary Progressive Multiple Sclerosis"
sidebar: mydoc_sidebar
permalink: db11988-mesh-d020528-1.html
toc: false 
---


Path ID: `DB11988_MESH_D020528_1`
{% include image.html url="images/db11988-mesh-d020528-1.png" file="db11988-mesh-d020528-1.png" alt="db11988-mesh-d020528-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C533411 | Ocrelizumab | Drug |
| UniProt:P11836 | B-lymphocyte antigen CD20 | Protein |
| CL:0000236 | B cell | Cell |
| MESH:D020528 | Primary progressive multiple sclerosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ocrelizumab | NEGATIVELY REGULATES | B-Lymphocyte Antigen Cd20 |
| B-Lymphocyte Antigen Cd20 | EXPRESSED IN | B Cell |
| B Cell | CONTRIBUTES TO | Primary Progressive Multiple Sclerosis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB11988](https://go.drugbank.com/drugs/DB11988)
